 Mylan N.V. Nasdaq: MYL today announced that its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan and Upjohn, a division of Pfizer, at the companys extraordinary general meeting of shareholders. Approximately 99.6 of votes cast were voted in favor of the combination. 